HIF1A and ovarian cancer: To assess the role of HIF-1 activity in the resistance conferred by Rab25 expression, cisplatin sensitivity was determined by MTT assay in Rab25shHIF-1β, shScramble-Rab25 and SKOV3 ovarian cancer cells.